CYP cynata therapeutics limited

Sorry no one answered your question. The short answer is no, it...

  1. 1,044 Posts.
    lightbulb Created with Sketch. 53
    Sorry no one answered your question.
    The short answer is no, it is not a must have for duplication.
    What it is though is a must have for affordable duplication. Other methods of duplication result in a finite amount of cells from a single donation/harvest meaning the cost of manufacturing is relatively high resulting in high cost of treatment. CYP can duplicate basically an infinite amount from a single donation/harvest which significantly lowers production and treatment costs. CYP will eventually bring affordable stem cell based therapies to the masses. When is the big question as we are dragging our feet a bit.

    All the above is before we even start to look at efficacy of one cell compared to another (ours are very good).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
16.5¢ 16.5¢ 16.5¢ $330 2K

Buyers (Bids)

No. Vol. Price($)
1 2450 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 82871 5
View Market Depth
Last trade - 10.17am 23/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.